CD274 and neoplasm: While complete excision remains the most important factor for long-term control, more recently, immune checkpoint inhibitors targeting PD-1/PD-L1 have demonstrated encouraging responses, particularly when combined with TKIs, opening the way for multimodal strategies in this rare tumor.37